Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
cold-like symptoms; coughing; sneezing; runny nose; feeling sick; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 28-OCT-2022, the patient received the 1st dose of Shingrix. On 28-OCT-2022, less than a day after receiving Shingrix, the patient experienced feeling unwell (Verbatim: feeling sick). On an unknown date, the patient experienced cold symptoms (Verbatim: cold-like symptoms), cough (Verbatim: coughing), sneezing (Verbatim: sneezing) and runny nose (Verbatim: runny nose). The patient was treated with phenoxymethylpenicillin (Penicillin). The outcome of the feeling unwell, cold symptoms, cough, sneezing and runny nose were not resolved. It was unknown if the reporter considered the feeling unwell, cold symptoms, cough, sneezing and runny nose to be related to Shingrix. It was unknown if the company considered the feeling unwell, cold symptoms, cough, sneezing and runny nose to be related to Shingrix. Additional Information: GSK Receipt Date: 29-JAN-2025 The reporter reported that a patient received Shingrix and on that same day she started feeling sick. She did not get dose 2. She has had cold-like symptoms, coughing sneezing, and runny nose. Patient had penicillin twice and 3 rounds of antibiotics and states she has not gotten better since. She had not recovered.